1. Home
  2. |Insights
  3. |COVID-19 Roundtable Discussion: Practical Guidance for Legal Departments, Business Leaders, and Boards

COVID-19 Roundtable Discussion: Practical Guidance for Legal Departments, Business Leaders, and Boards

Webinar | 03.10.20, 8:00 AM EDT - 9:00 AM EDT

Register

Please join us for a webinar that will discuss some of the key business and legal issues that companies are navigating in connection with the Coronavirus (COVID-19) and its cross-jurisdictional impacts. Topics will include supply chain disruption, labor and employment, employee mobility, commercial contracts, government contracts, health care, insurance coverage, privacy, crisis management and continuity of operations, and more. 


The format of the webinar will be a roundtable discussion led by members of Crowell & Moring’s COVID-19 multi-disciplinary working group.  The team includes lawyers with senior government, industry and legal experience relevant to this rapidly evolving situation.  We will address real time issues and concerns and provide practical guidance and approaches. We hope you will join our team for this free webinar.


Speakers

  • Bryan Brewer, Partner, Washington, D.C.
  • Michelle Coleman, Counsel, Washington, D.C.
  • Jodi Daniel, Partner, Washington, D.C.
  • Peter Eyre, Partner, Washington, D.C.
  • Laura Foggan, Partner, Washington, D.C.
  • Tom Gies, Partner, Washington, D.C.
  • Paul Rosen, Partner, Los Angeles
  • Nicole Simonian, Partner, Los Angeles
  • Evan Wolff, Partner, Washington, D.C.

For more information, please visit our Coronavirus Resources page.

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights